These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4688801)

  • 1. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients.
    Chretien PB; Crowder WL; Gertner HR; Sample WF; Catalona WJ
    Surg Gynecol Obstet; 1973 Mar; 136(3):380-4. PubMed ID: 4688801
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of immune reactivity and clinical status in cancer.
    Chretien PB; Catalona WJ; Twomey PL; Sample WF
    Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.
    Catalona WJ; Sample WF; Chretien PB
    Cancer; 1973 Jan; 31(1):65-71. PubMed ID: 4683045
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative dinitrochlorobenzene contact sensitivity in preoperative and cured cancer patients.
    Chretien PB; Twomey PL; Trahan EE; Catalona WJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():263-6. PubMed ID: 4787068
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.
    Sample WF; Gertner HR; Chretien PB
    J Natl Cancer Inst; 1971 Jun; 46(6):1291-7. PubMed ID: 5088049
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Cellular immunity in cured cancer patients.
    Twomey PL; Catalona WJ; Chretien PB
    Cancer; 1974 Feb; 33(2):435-40. PubMed ID: 4812762
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology.
    Catalona WJ; Chretien PB
    Cancer; 1973 Feb; 31(2):353-6. PubMed ID: 4687881
    [No Abstract]   [Full Text] [Related]  

  • 8. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
    Bolton PM
    Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
    [No Abstract]   [Full Text] [Related]  

  • 9. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
    Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.
    Anderson RJ; McBride CM; Hersh EM
    Cancer Res; 1972 May; 32(5):988-92. PubMed ID: 4336032
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on immunological responsiveness of cancer patients. II. Phytohemagglutinin-stimulated lymphocyte transformation in patients with gastric or esophageal cancer].
    Kumashiro R
    Fukuoka Igaku Zasshi; 1976 Sep; 67(9):339-49. PubMed ID: 1033895
    [No Abstract]   [Full Text] [Related]  

  • 12. [The alternation of peripheral lymphocyte subsets in head and neck carcinoma].
    Mitarai K; Tsukuda M; Mochimatsu I; Kubota A; Sawaki S
    Gan No Rinsho; 1986 Jul; 32(8):849-54. PubMed ID: 3747146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response to phytohaemagglutinin (PHA) of lymphocytes from cancer patients.
    Kumar S; Taylor G
    J Clin Pathol; 1973 Jul; 26(7):476-9. PubMed ID: 4727057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
    Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
    Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of the subsets of lymphocyte in the peripheral blood of the head and neck cancer patients].
    Okamoto M; Takahashi H; Yao K; Fujino A; Ishii T; Harada K; Yagi A; Yoshio S; Yagi K; Furusawa S
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr; 88(4):443-8. PubMed ID: 4032110
    [No Abstract]   [Full Text] [Related]  

  • 17. Baboon peripheral lymphocyte response to phytohaemagglutinin.
    Burgess BJ; Vos GH; Grobbelaar BG
    S Afr J Med Sci; 1972 Dec; 37(3):69-71. PubMed ID: 4204105
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of poor CD3 response in head and neck cancer.
    Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
    Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histocompatibility antigens and solid malignant neoplasms.
    Tarpley JL; Chretien PB; Rogentine GN; Twomey PL; Dellon AL
    Arch Surg; 1975 Mar; 110(3):269-71. PubMed ID: 163628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic abnormalities in head and neck cancer.
    Eilber FR; Morton DL; Ketcham AS
    Am J Surg; 1974 Oct; 128(4):534-8. PubMed ID: 4422512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.